Trial Profile
Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes."
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 22 Mar 2017 Status changed from recruiting to completed.
- 04 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 08 May 2015 New trial record